Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Musculoskeletal
Clinical Trials: Myelofibrosis
A listing of clinical trials currently looking for volunteers to enroll in Myelofibrosis studies. Click on the closest city to find more detailed information on a research study in your area.
California
Stanford : Stanford University Medical center
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adults With Myelofibrosis
Florida
Winter Park :
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
Maryland
Baltimore :
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
North Dakota
Pennsylvania
Norristown : Luitpold Pharmaceuticals, Inc.
Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Texas
Houston : MD Anderson Cancer Center
A Phase 2 Study to Evaluate the Efficacy and Safety of AB0024 in Adults With Myelofibrosis
Houston : University of Texas M.D. Anderson Cancer Center
Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias
Houston :
Study of the JAK Inhibitor Ruxolitinib Administered Orally to Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia-Myelofibrosis (PET-MF)
Houston : MD Anderson Cancer Center
TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation
